Charles River Laboratories International, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Charles River Laboratories International, Inc. (CRL) holds an ST Score of 48.9 out of 100 (C+), with its strongest factor being Sentiment (A+) and its weakest Financial Strength (D). Analysts rate CRL Buy across 37 ratings with a $282.36 average price target (+0.0% vs the current $279.01).
- Strongest
- SentimentA+
- Weakest
- Financial StrengthD
All factor grades
- SentimentA+
- MomentumB
- ProfitabilityC+
- ForecastC+
- GrowthC
- ValuationC-
- Financial StrengthD
- Piotroski5/9
Contact
CRL stock: frequently asked questions
What is CRL's ST Score?
Charles River Laboratories International, Inc. (CRL) has an ST Score of 48.9 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CRL a buy, sell, or hold?
Wall Street's consensus rating on CRL is Buy based on 37 analyst ratings. Our own ST Score grades it C+ (48.9/100). This is data, not investment advice — always do your own research.
What is CRL's valuation grade?
Charles River Laboratories International, Inc. (CRL) earns a valuation grade of C-, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CRL's growth grade?
Charles River Laboratories International, Inc. (CRL) earns a growth grade of C, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CRL's profitability grade?
Charles River Laboratories International, Inc. (CRL) earns a profitability grade of C+, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CRL's financial strength grade?
Charles River Laboratories International, Inc. (CRL) earns a financial strength grade of D, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CRL?
The average analyst price target for Charles River Laboratories International, Inc. (CRL) is $282.36 from 37 analysts, which is +0.0% versus the recent price of $279.01.
What is CRL's Piotroski score?
Charles River Laboratories International, Inc. (CRL) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.